Travel Insurance with Liver Disease UK 2026: Cirrhosis, Hepatitis and NAFLD Cover

Travel insurance with liver disease is available from UK specialist providers, but the range of conditions grouped under this category, from mild NAFLD to decompensated cirrhosis, generates a wide range of underwriting outcomes. Understanding where each specific liver condition sits in the underwriting spectrum and which providers are appropriate for each profile ensures travellers obtain cover that is both genuine and appropriately scoped.

Liver Conditions and Their Underwriting Profiles

Non-alcoholic fatty liver disease (NAFLD) at the early or mild stage, without significant fibrosis and with normal or near-normal liver function tests, is the most straightforward liver condition to place in the specialist market. Mild NAFLD without complications is likely to generate a modest loading from mainstream specialist providers including Staysure, Avanti and JustTravelCover through automated online screening. More advanced NAFLD with significant fibrosis requires more detailed assessment.

Hepatitis C that has been successfully treated with direct-acting antiviral (DAA) therapy and has achieved sustained virological response (SVR12 or later) is treated increasingly favourably in travel insurance underwriting. Confirmed SVR with normal liver function tests significantly improves the underwriting outcome relative to untreated hepatitis C. Travellers who have recently completed DAA treatment should declare the SVR status and the most recent liver function test results accurately.

Hepatitis B, whether chronic active or chronic inactive, generates an individual underwriting assessment. Chronic inactive hepatitis B with normal liver function tests and no antiviral treatment is typically easier to place than chronic active hepatitis B with elevated viral load or antiviral treatment. The distinction between e-antigen positive and e-antigen negative chronic hepatitis B, and the current viral load and liver function status, are the key underwriting variables.

Cirrhosis is the most complex liver condition underwriting category. The Child-Pugh score or MELD score reflecting disease severity, the presence or absence of complications including ascites, hepatic encephalopathy, spontaneous bacterial peritonitis, oesophageal or gastric varices and portal hypertension, and any history of variceal haemorrhage are all material underwriting variables. Compensated cirrhosis without complications and with stable liver function is materially different from decompensated cirrhosis with active complications. The specialist providers most capable of accommodating the full spectrum of cirrhosis severity are GoodToGo, Freedom Insure and iAmInsured.

Which Providers Cover Liver Disease

Staysure, Avanti, InsureandGo and JustTravelCover can all consider mild to moderate liver disease without complications through automated online screening. NAFLD, treated hepatitis C with SVR, and compensated cirrhosis without complications are the profiles most likely to generate terms from these mainstream specialist providers. GoodToGo and Freedom Insure are the appropriate route for more complex liver disease profiles including advanced cirrhosis with complications, untreated hepatitis C with active viral replication, and liver conditions co-occurring with other significant health issues. iAmInsured is the specialist of last resort for travellers with advanced decompensated cirrhosis, recent variceal haemorrhage, active hepatic encephalopathy or liver disease at a stage where transplant listing is under consideration.

Destination Considerations

Access to specialist hepatology or gastroenterology services at the destination matters significantly for travellers with cirrhosis or active hepatitis where emergency hospital treatment may be required. Hepatitis A and B vaccination status should be confirmed before travel to destinations where these infections are endemic: hepatitis A superinfection in a patient with pre-existing chronic liver disease carries significantly higher morbidity than in a healthy traveller. Yellow fever vaccination is contraindicated in patients with advanced liver disease and destination yellow fever requirements should be discussed with the treating hepatologist before booking. The emergency medical cover limit is highly relevant for liver disease travellers: acute decompensation of cirrhosis requiring ICU admission in the United States can generate hospital costs of tens of thousands of pounds within days.

Fitness to Travel and Documentation

A letter from the treating hepatologist confirming diagnosis, current liver function status, the absence of active complications and fitness to travel is important for liver disease travellers. This letter serves the travel insurance screening process, provides essential clinical context for any overseas medical consultation, and in some cases is a requirement for boarding certain cruise ships where the treating physician's fit-to-travel assessment is mandatory for passengers with known serious conditions. Having recent liver function test results available during the online screening process enables a more accurate and often more favourable underwriting assessment.

UK Regulatory Framework for Travel Insurance

All UK travel insurance policies sold to UK residents are regulated by the Financial Conduct Authority under the Insurance Conduct of Business sourcebook, known as ICOBS. ICOBS sets out requirements for product disclosure, fair treatment of customers and the handling of claims and complaints. Any insurer or distributor that breaches ICOBS is subject to FCA enforcement action including financial penalties, public censure and in serious cases prohibition from regulated activities.

The Consumer Duty, which came into force on 31 July 2023 under Policy Statement PS22/9, adds a cross-cutting standard requiring all FCA-regulated firms to deliver good outcomes for retail customers. For travel insurance specifically, the Consumer Duty places obligations on insurers to ensure that products are accessible and fair for customers with characteristics of vulnerability. Older travellers and those with pre-existing medical conditions are explicitly identified in the FCA's guidance as groups that face systematic disadvantage in the standard insurance market and that require particular consideration under the Consumer Duty framework. The four outcome areas of the Consumer Duty are products and services, price and value, consumer understanding, and consumer support. Each area has specific application to the specialist pre-existing conditions travel insurance market.

The Consumer Insurance (Disclosure and Representations) Act 2012 governs the disclosure obligations of all UK travel insurance policyholders. Under this Act, policyholders must take reasonable care not to make a misrepresentation when answering an insurer's screening questions. A deliberate or reckless misrepresentation entitles the insurer to avoid the policy in full and deny all claims regardless of whether the specific claim relates to the undisclosed condition. An inadvertent misrepresentation results in a proportionate remedy: if the insurer would not have written the policy at all, it may avoid but must return the premium; if it would have written at a higher premium, it may reduce the claim proportionately to reflect the premium difference.

The Financial Ombudsman Service is the statutory alternative dispute resolution body for all UK travel insurance complaints. The FOS can award compensation of up to £430,000 per complaint and its decisions are binding on all FCA-regulated firms. Travellers who disagree with any claim decision from any FCA-regulated travel insurer have the right to refer their complaint to the FOS free of charge after the insurer has had eight weeks to respond to the formal complaint. The FOS publishes biannual complaint data covering complaint volumes and uphold rates for named firms, providing an independent public benchmark of claims handling quality across the travel insurance market that is not dependent on provider marketing claims.

The Association of British Insurers publishes guidance on travel insurance best practice, including recommended minimum emergency medical cover limits. The ABI recommends a minimum of £2 million for European travel and at least £5 million for long-haul destinations. For travel to the United States specifically, where private hospital costs can frequently exceed £10,000 per day before surgical intervention or repatriation costs, the ABI guidance points to higher limits of £10 million or more for extended stays. The ABI also notes that cancellation underinsurance is one of the most common causes of partial claim settlements in the travel insurance market, and recommends that travellers ensure their cancellation cover is sufficient to cover the full prepaid cost of their trip including flights, accommodation and pre-booked excursions.

The Global Health Insurance Card, the GHIC, replaced the European Health Insurance Card for UK travellers after the Brexit transition period ended on 31 December 2020. The GHIC provides access to state healthcare in participating European Economic Area countries on the same terms as local residents. It does not cover private treatment, emergency repatriation, trip cancellation, baggage loss, personal liability or any other component of a comprehensive travel insurance policy. The FCA and ABI both advise UK travellers to carry both a valid GHIC and a comprehensive travel insurance policy when travelling in Europe. The two instruments are complementary rather than interchangeable, and holding a GHIC does not reduce the need for travel insurance in any European destination.

Frequently Asked Questions

Can I get travel insurance with liver disease in the UK?

Yes. UK specialist travel insurance providers can consider liver disease through individual screening. Mild to moderate liver disease without complications can be placed by mainstream specialist providers. Advanced cirrhosis with complications requires telephone screening from GoodToGo, Freedom Insure or iAmInsured.

Does treated hepatitis C affect travel insurance?

Hepatitis C successfully treated with direct-acting antivirals and with confirmed sustained virological response is treated more favourably in underwriting than untreated hepatitis C. Confirmed SVR with normal liver function tests significantly improves the screening outcome.

Can I get travel insurance with cirrhosis?

Compensated cirrhosis without active complications can typically be placed by specialist providers including GoodToGo and Freedom Insure. Decompensated cirrhosis with active ascites, encephalopathy or variceal history requires telephone screening and may require iAmInsured for the most severe presentations.

Do I need to declare NAFLD for travel insurance?

Yes. Non-alcoholic fatty liver disease must be declared. The Consumer Insurance (Disclosure and Representations) Act 2012 requires accurate disclosure of all pre-existing conditions including liver conditions.